Viiv Healthcare
Clinical trials sponsored by Viiv Healthcare, explained in plain language.
-
New HIV drug candidate enters first human safety tests
Disease control Not yet recruitingThis early-stage study tests a new experimental HIV drug, VH4770359, in 214 healthy adults aged 18 to 55. The main goal is to check if the drug is safe and how the body processes it. Results will help design future studies in people living with HIV.
Phase: PHASE1 • Sponsor: ViiV Healthcare • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
HIV patients to keep receiving promising treatment in new Follow-Up study
Disease control Not yet recruitingThis study offers continued access to an HIV treatment for up to 183 people who completed a previous ViiV Healthcare study and are still doing well on it. The goal is to keep providing the treatment while monitoring safety. Participants must have a doctor's confirmation that they…
Phase: PHASE3 • Sponsor: ViiV Healthcare • Aim: Disease control
Last updated May 18, 2026 12:03 UTC